AlphaYouSR
Insider selling
Simrat Randhawa sold $2.5M of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock
Simrat Randhawa, EVP, Head of R&D of Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 23,124 shares of DNTH stock worth $2.5M, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 1, 2026, 2 days before it was made public.
DNTH has moved -7.8% since the trade date, from $106.62 to $98.35 (Sep 22, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 2 days
- Price since
- -7.8%
- Role
- EVP, Head of R&D
- Source
- SEC Form 4
More DNTH insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.